MoneyWorks4Me

Alkem Laboratories informs about related party transactions

30 Nov 2021 Evaluate

Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Alkem Laboratories has informed that it enclosed disclosures of related party transactions, on a consolidated basis, for the half year ended on 30th September, 2021 in the prescribed format. The same have been published on the website of the Company at www.alkemlabs.com.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1782.00
Dr. Reddys Labs. 1208.00
Cipla 1334.00
Lupin 2010.00
Zydus Lifesciences 1138.50
View more..